Market News & Trends
CoreRx Adds Additional Capabilities With New Tablet Press
CoreRx, a leader in early drug contract development, has expanded manufacturing capabilities to include the OYSTAR Manesty FLEXITAB, a fully automated, single station tablet press…
Novozymes to Supply Recombumin for Type 2 Diabetes Drug
Novozymes to Supply Recombumin for Type 2 Diabetes Drug Novozymes Biopharma, part of Novozymes A/S, recently announced it has concluded an exclusive supply agreement with…
Silence Therapeutics Signs siRNA Delivery Collaboration
Silence Therapeutics plc, a leading RNA interference (RNAi) therapeutics company, recently announced it has entered into an agreement with one of the world's leading global…
Talon Therapeutics' NDA Accepted for Filing by US FDA Under Subpart H
Talon Therapeutics, Inc. recently announced its NDA seeking accelerated approval of Marqibo (vincristine sulfate liposomes injection) has been accepted for filing by the FDA. Marqibo…
UPM Pharmaceuticals to Add Low Humidity, OEB 4 & Specialized Xcelodose Manufacturing Capability
UPM Pharmaceuticals recently announced it will expand its existing manufacturing capacity, including an OEB 4 processing room, a low humidity processing suite, and a unique…
First Application of Haselmeier's Injection Pen Launched
Haselmeier recently announced that the first application of its Axis-D pen platform has been launched. Commissioned by its client Merck Serono, a division of Merck…
Kythera Biopharmaceuticals Raises $37.4-Million Financing
KYTHERA Biopharmaceuticals, Inc. recently announced the closing of a $37.4-million Series D financing. The round featured significant new investments as well as participation from all…
Loxbridge & Dr. Kary Mullis Announce the Formation of Altermune Technologies
Dr. Kary Mullis, the Nobel Prize-winning inventor of the Polymerase Chain Reaction (PCR), the cornerstone of much of today's DNA science, has entered a new…
Thermo Fisher Scientific Introduces New Imaging ATR Accessory
Thermo Fisher Scientific Inc., a world leader in serving science, recently announced the launch of a new imaging attenuated total reflectance (ATR) accessory offering enhanced…
Unigene Divests Non-Core Asset & Focuses Resources on High Valuation Drug Development & Peptide Delivery
Unigene Laboratories, Inc. recently announced it has divested its non-core asset, Site Directed Bone Growth (SDBG) by assigning seven patent applications to Kieran Murphy, LLC.…
9/27/2011
Thermo Fisher Scientific Introduces New Imaging ATR Accessory Thermo Fisher Scientific Inc., a world leader in serving science, recently announced the launch of a new…
Ambrx & BMS Announce $24-Million Collaboration for Novel Biologics Programs
Ambrx, Inc. and Bristol-Myers Squibb Company recently announced a collaboration under which Bristol-Myers Squibb will receive exclusive worldwide rights to research, develop, and commercialize biologics…
Alkermes Launches Corporate Operations in Ireland
Alkermes plc recently announced the establishment of its corporate operations in Ireland, with new headquarters located in Dublin. The company, including its headquarters and operations…
9/20/2011
Unilife Develops Proprietary Portfolio of Wearable Subcutaneous Infusion Devices Unilife Corporation recently announced the development of its AutoInfusor portfolio of subcutaneous infusion systems for…
BioSante Pharmaceuticals Successfully Completes LibiGel Pharmacokinetic Study
BioSante Pharmaceuticals, Inc. recently announced successful completion of its principal LibiGel (testosterone gel) pharmacokinetic (PK) study. The top-line results indicate that LibiGel increases levels of…
F-Star & Merck Serono to Collaborate on Novel Targeted Biologics
F-Star GmbH recently announced that a research, license, and commercialization agreement was signed with Merck Serono, a division of Merck KGaA, Darmstadt, Germany, for the…
KAI Pharmaceuticals Inks $13-Million Development Deal With Ono Pharmaceutical
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, recently announced the signing of an agreement with Ono Pharmaceutical Co., Ltd. for the…
NanoSmart Begins Development of New Drug Delivery Platform for Cancer
NanoSmart Pharmaceuticals, Inc., a biopharmaceutical corporation developing novel cancer pharmaceuticals, has moved into its new corporate facility located in Laguna Hills, CA. The facility provides…
Unilife Develops Proprietary Portfolio of Wearable Subcutaneous Infusion Devices
Unilife Corporation recently announced the development of its AutoInfusor portfolio of subcutaneous infusion systems for the patient self-administration of drugs in 3-, 5-, 7-, and…
PerkinElmer to Acquire Caliper Life Sciences for $600 Million
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, recently announced it has signed a definitive agreement…
